nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyruvic acid—Acetohydroxamic Acid—Hydroxyurea—psoriasis	0.964	1	CrCrCtD
Pyruvic acid—SLC16A8—tendon—psoriasis	0.00246	0.137	CbGeAlD
Pyruvic acid—SLC16A5—tendon—psoriasis	0.00193	0.107	CbGeAlD
Pyruvic acid—SLC16A6—tendon—psoriasis	0.00187	0.104	CbGeAlD
Pyruvic acid—SLC16A4—tendon—psoriasis	0.00172	0.0953	CbGeAlD
Pyruvic acid—PKM—skin of body—psoriasis	0.00163	0.0906	CbGeAlD
Pyruvic acid—PC—skin of body—psoriasis	0.00151	0.0836	CbGeAlD
Pyruvic acid—PDHB—The citric acid (TCA) cycle and respiratory electron transport—NDUFA5—psoriasis	0.00136	0.0765	CbGpPWpGaD
Pyruvic acid—PDHB—tendon—psoriasis	0.0013	0.0723	CbGeAlD
Pyruvic acid—PKM—tendon—psoriasis	0.00124	0.0689	CbGeAlD
Pyruvic acid—PKM—HIF-1-alpha transcription factor network—CP—psoriasis	0.00105	0.0594	CbGpPWpGaD
Pyruvic acid—SLC16A8—The citric acid (TCA) cycle and respiratory electron transport—NDUFA5—psoriasis	0.00103	0.058	CbGpPWpGaD
Pyruvic acid—SLCO2A1—skin of body—psoriasis	0.000881	0.0489	CbGeAlD
Pyruvic acid—SLC16A7—tendon—psoriasis	0.000876	0.0487	CbGeAlD
Pyruvic acid—ABAT—tendon—psoriasis	0.000833	0.0463	CbGeAlD
Pyruvic acid—SLCO2A1—tendon—psoriasis	0.00067	0.0372	CbGeAlD
Pyruvic acid—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—NDUFA5—psoriasis	0.000662	0.0374	CbGpPWpGaD
Pyruvic acid—SLC16A8—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.000636	0.0359	CbGpPWpGaD
Pyruvic acid—SLC16A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000624	0.0352	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—SERPINB8—psoriasis	0.000593	0.0335	CbGpPWpGaD
Pyruvic acid—SLC16A1—tendon—psoriasis	0.000558	0.031	CbGeAlD
Pyruvic acid—SLC16A10—tendon—psoriasis	0.000541	0.03	CbGeAlD
Pyruvic acid—SLC16A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000509	0.0287	CbGpPWpGaD
Pyruvic acid—PKM—HIF-1-alpha transcription factor network—LEP—psoriasis	0.00048	0.0271	CbGpPWpGaD
Pyruvic acid—PKM—HIF-1-alpha transcription factor network—NOS2—psoriasis	0.000448	0.0252	CbGpPWpGaD
Pyruvic acid—SLC16A3—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.00041	0.0231	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000402	0.0227	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—SERPINB8—psoriasis	0.000382	0.0216	CbGpPWpGaD
Pyruvic acid—AGXT2—Nucleotide metabolism—CAT—psoriasis	0.000371	0.0209	CbGpPWpGaD
Pyruvic acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—NDUFA5—psoriasis	0.000358	0.0202	CbGpPWpGaD
Pyruvic acid—PKM—HIF-1-alpha transcription factor network—JUN—psoriasis	0.000297	0.0167	CbGpPWpGaD
Pyruvic acid—SLC16A8—SLC-mediated transmembrane transport—CP—psoriasis	0.000284	0.016	CbGpPWpGaD
Pyruvic acid—PKM—HIF-1-alpha transcription factor network—VEGFA—psoriasis	0.000259	0.0146	CbGpPWpGaD
Pyruvic acid—SLC16A7—SLC-mediated transmembrane transport—CP—psoriasis	0.000231	0.013	CbGpPWpGaD
Pyruvic acid—SLC16A1—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.000221	0.0125	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000217	0.0122	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—SERPINB8—psoriasis	0.000207	0.0116	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—NDUFA5—psoriasis	0.000205	0.0115	CbGpPWpGaD
Pyruvic acid—SLCO2A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000202	0.0114	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—NDUFA5—psoriasis	0.000192	0.0108	CbGpPWpGaD
Pyruvic acid—SLC16A3—SLC-mediated transmembrane transport—CP—psoriasis	0.000183	0.0103	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—CYP2S1—psoriasis	0.000174	0.00981	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—ITGAL—psoriasis	0.000172	0.00972	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—CYP2S1—psoriasis	0.000164	0.00922	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—CARM1—psoriasis	0.000162	0.00913	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—NDUFA5—psoriasis	0.000155	0.00874	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—NDUFA5—psoriasis	0.000155	0.00874	CbGpPWpGaD
Pyruvic acid—SLC16A8—Transmembrane transport of small molecules—CP—psoriasis	0.000144	0.00813	CbGpPWpGaD
Pyruvic acid—SLC16A8—Transmembrane transport of small molecules—CARM1—psoriasis	0.000137	0.00775	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—NDUFA5—psoriasis	0.000132	0.00744	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—CYP2S1—psoriasis	0.000132	0.00744	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—CYP2S1—psoriasis	0.000132	0.00744	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—NDUFA5—psoriasis	0.000122	0.00686	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transmembrane transport of small molecules—CP—psoriasis	0.000117	0.00663	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—CYP2S1—psoriasis	0.000112	0.00632	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transmembrane transport of small molecules—CARM1—psoriasis	0.000112	0.00632	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—ITGAL—psoriasis	0.000111	0.00626	CbGpPWpGaD
Pyruvic acid—SLC16A10—SLC-mediated transmembrane transport—CP—psoriasis	0.000111	0.00626	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—CYP2S1—psoriasis	0.000103	0.00583	CbGpPWpGaD
Pyruvic acid—SLCO2A1—Transmembrane transport of small molecules—CP—psoriasis	0.000103	0.00579	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—NDUFA5—psoriasis	9.99e-05	0.00564	CbGpPWpGaD
Pyruvic acid—SLC16A1—SLC-mediated transmembrane transport—CP—psoriasis	9.87e-05	0.00557	CbGpPWpGaD
Pyruvic acid—SLCO2A1—Transmembrane transport of small molecules—CARM1—psoriasis	9.8e-05	0.00552	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transmembrane transport of small molecules—CP—psoriasis	9.29e-05	0.00524	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transmembrane transport of small molecules—CARM1—psoriasis	8.86e-05	0.005	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—CYP2S1—psoriasis	8.5e-05	0.00479	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—CARM1—psoriasis	8.5e-05	0.00479	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—CARM1—psoriasis	7.99e-05	0.0045	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—LEP—psoriasis	7.74e-05	0.00436	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—NOS2—psoriasis	7.07e-05	0.00399	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—PPARG—psoriasis	6.74e-05	0.0038	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—CARM1—psoriasis	6.44e-05	0.00363	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—CARM1—psoriasis	6.44e-05	0.00363	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—ITGAL—psoriasis	6e-05	0.00338	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—TYK2—psoriasis	5.9e-05	0.00333	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—CP—psoriasis	5.64e-05	0.00318	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—CARM1—psoriasis	5.47e-05	0.00309	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—NDUFA5—psoriasis	5.4e-05	0.00304	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—CARM1—psoriasis	5.38e-05	0.00304	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—CAT—psoriasis	5.23e-05	0.00295	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—CARM1—psoriasis	5.05e-05	0.00285	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—CP—psoriasis	5.01e-05	0.00283	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—CAT—psoriasis	4.91e-05	0.00277	CbGpPWpGaD
Pyruvic acid—PKM—Disease—HLA-A—psoriasis	4.88e-05	0.00275	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—CARM1—psoriasis	4.78e-05	0.0027	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—NFKB1—psoriasis	4.6e-05	0.00259	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—CYP2S1—psoriasis	4.59e-05	0.00259	CbGpPWpGaD
Pyruvic acid—PKM—Disease—APOE—psoriasis	4.56e-05	0.00257	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—NOS2—psoriasis	4.56e-05	0.00257	CbGpPWpGaD
Pyruvic acid—PKM—Disease—NOS2—psoriasis	4.25e-05	0.0024	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—VEGFA—psoriasis	4.18e-05	0.00236	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—CARM1—psoriasis	4.15e-05	0.00234	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—STAT3—psoriasis	4.13e-05	0.00233	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—VEGFA—psoriasis	4.1e-05	0.00231	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—APOE—psoriasis	4.06e-05	0.00229	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—CAT—psoriasis	3.96e-05	0.00223	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—CAT—psoriasis	3.96e-05	0.00223	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—HLA-A—psoriasis	3.94e-05	0.00222	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—APOE—psoriasis	3.82e-05	0.00215	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—APOE—psoriasis	3.67e-05	0.00207	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—TNF—psoriasis	3.58e-05	0.00202	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—PPARG—psoriasis	3.54e-05	0.00199	CbGpPWpGaD
Pyruvic acid—PKM—Disease—TYK2—psoriasis	3.48e-05	0.00196	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—NOS2—psoriasis	3.42e-05	0.00193	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—CAT—psoriasis	3.37e-05	0.0019	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—PPARG—psoriasis	3.33e-05	0.00188	CbGpPWpGaD
Pyruvic acid—PKM—Disease—CD4—psoriasis	3.15e-05	0.00177	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—CAT—psoriasis	3.11e-05	0.00175	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—TP53—psoriasis	3.1e-05	0.00175	CbGpPWpGaD
Pyruvic acid—PC—Disease—HLA-A—psoriasis	3.09e-05	0.00174	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—APOE—psoriasis	3.08e-05	0.00174	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—APOE—psoriasis	3.08e-05	0.00174	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—IL6—psoriasis	2.89e-05	0.00163	CbGpPWpGaD
Pyruvic acid—PC—Disease—APOE—psoriasis	2.88e-05	0.00163	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—TYK2—psoriasis	2.8e-05	0.00158	CbGpPWpGaD
Pyruvic acid—PC—Disease—NOS2—psoriasis	2.69e-05	0.00152	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—PPARG—psoriasis	2.68e-05	0.00151	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—PPARG—psoriasis	2.68e-05	0.00151	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—VEGFA—psoriasis	2.64e-05	0.00149	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—APOE—psoriasis	2.62e-05	0.00148	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—CAT—psoriasis	2.55e-05	0.00144	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—CD4—psoriasis	2.54e-05	0.00143	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—NOS2—psoriasis	2.46e-05	0.00139	CbGpPWpGaD
Pyruvic acid—PKM—Disease—STAT3—psoriasis	2.44e-05	0.00137	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—APOE—psoriasis	2.41e-05	0.00136	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—PPARG—psoriasis	2.28e-05	0.00129	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—CARM1—psoriasis	2.24e-05	0.00126	CbGpPWpGaD
Pyruvic acid—PC—Disease—TYK2—psoriasis	2.2e-05	0.00124	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—PPARG—psoriasis	2.1e-05	0.00119	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—TP53—psoriasis	1.99e-05	0.00112	CbGpPWpGaD
Pyruvic acid—PC—Disease—CD4—psoriasis	1.99e-05	0.00112	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—APOE—psoriasis	1.98e-05	0.00112	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—STAT3—psoriasis	1.96e-05	0.00111	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—PPARG—psoriasis	1.73e-05	0.000974	CbGpPWpGaD
Pyruvic acid—PKM—Disease—IL6—psoriasis	1.7e-05	0.00096	CbGpPWpGaD
Pyruvic acid—PC—Disease—STAT3—psoriasis	1.54e-05	0.000869	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—VEGFA—psoriasis	1.43e-05	0.000804	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—CAT—psoriasis	1.38e-05	0.000777	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—IL6—psoriasis	1.37e-05	0.000774	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—TP53—psoriasis	1.08e-05	0.000607	CbGpPWpGaD
Pyruvic acid—PC—Disease—IL6—psoriasis	1.08e-05	0.000607	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—APOE—psoriasis	1.07e-05	0.000604	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—PPARG—psoriasis	9.33e-06	0.000526	CbGpPWpGaD
